Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease’s Burdens from Prevention to Cure

By /

Brii Biosciences Limited announced that it has entered into license agreements with VBI Vaccines, Inc., expanding the companies’ collaboration in the hepatitis B virus field.

Scroll to Top